Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Footer revision indicator updated from Revision: v3.4.2 to Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-06T17:54:05.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Generalized pustular psoriasis as a condition reference and introduced a Resources section with a link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-02-27T18:22:46.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. This is a routine platform update with no evident changes to the study information.
    Difference
    0.1%
    Check dated 2026-02-13T12:48:04.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1. No changes to study content or navigation are evident.
    Difference
    0.1%
    Check dated 2026-02-06T09:22:04.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now shows a glossary toggle and adds metadata fields such as Last Update Submitted that Met QC Criteria and Last Update Posted, along with No FEAR Act Data. Versioning was updated from Revision: v3.3.4 to v3.4.0 and some legacy labels were removed, reflecting labeling/UI updates rather than substantive data changes.
    Difference
    0.3%
    Check dated 2026-01-22T18:31:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the Study Details page with no changes to study data, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:36:38.000Z thumbnail image

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.